Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy
Recruiting
N/A
Interventional Study
BRCA1 Mutation
BRCA2 Mutation
At a Glance
- Age
- 19 – 50
- Sex
- Female
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 50 (estimated)
- Sponsor
- Duke University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to develop an educational aid about hormone replacement therapy that physicians can share with patients as part of their pre-surgical counseling for a risk-reducing salpingo-oophorectomy (RRSO).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* BRCA1 or BRCA2 germline mutation
* scheduled for a risk-reducing salpingo-oophorectomy (RRSO) by Duke Gynecologic Oncologist
* premenopausal
Exclusion Criteria:
* personal history of cancer
* postmenopausal
* \>50 years old
* unable to provide informed consent in English
Contacts